Joseph G. Pressey · Primary Ewing sarcoma of the brain: a case report and literature review
Follow
Article1 min read·Published Jan 2007Older

Primary Ewing sarcoma of the brain: a case report and literature review

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jan 2007 · 1 min read

In brief

In brief

This case report describes a rare primary CNS Ewing sarcoma in a 7-year-old with an anterior cranial fossa mass, confirmed by CD99 positivity and EWS-FLI1 fusion detection. The authors emphasize that molecular testing distinguishes CNS-EES from morphologically similar central PNETs, guiding appropriate treatment decisions.

Written by the GCMD Library team from the article.

Joseph G. Pressey

Ewing sarcoma, along with peripheral primitive neuroectodermal tumor, belongs to a tumor family that shares clinicopathologic and molecular genetic features, including the characteristic chromosomal translocation that results in the fusion of the EWS gene on 22q12 to either the FLI1 gene on 11q24 or other Ets family transcription factor gene, such as the ERG gene on 21q22. In contrast, such translocations are not found in central primitive neuroectodermal tumors (cPNETs), such as medulloblastoma and supratentorial PNET. Ewing sarcoma has only rarely been noted to primarily involve the central nervous system-extraosseous Ewing sarcoma (CNS-EES). We report a case of a 7-year-old girl with an anterior cranial fossa mass. Pathology showed a primitive small blue cell tumor with focal Homer Wright rosette formation. The positive membranous immunostaining for CD99 and the EWS-FLI1 fusion demonstrated by fluorescence in situ hybridization studies confirmed the diagnosis of CNS-EES. Although CNS-EES may look identical to cPNETs, these tumors differ in histogenesis, molecular characteristics, and clinical behavior. Demonstration of characteristic translocations by molecular studies differentiates CNS-EES from cPNET and help clinicians make informed decisions regarding therapy.

Statements in this article

  1. Ewing sarcoma and peripheral primitive neuroectodermal tumor share clinicopathologic and molecular genetic features, including characteristic chromosomal translocation resulting in fusion of the EWS gene on 22q12 to either the FLI1 gene on 11q24 or other Ets family transcription factor genes such as the ERG gene on 21q22.

    Established
  2. The characteristic EWS gene translocations found in Ewing sarcoma are not found in central primitive neuroectodermal tumors such as medulloblastoma and supratentorial PNET.

    Established
  3. Ewing sarcoma has only rarely been noted to primarily involve the central nervous system as extraosseous Ewing sarcoma (CNS-EES).

    Established
  4. Positive membranous immunostaining for CD99 and demonstration of EWS-FLI1 fusion by fluorescence in situ hybridization studies confirm the diagnosis of CNS-EES.

    Recommendation
  5. CNS-EES may look identical to central primitive neuroectodermal tumors but differs in histogenesis, molecular characteristics, and clinical behavior.

    Established
  6. Demonstration of characteristic translocations by molecular studies differentiates CNS-EES from cPNET and helps clinicians make informed decisions regarding therapy.

    Recommendation

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →
GCMD Library — educational content from recorded physician discussions, not medical advice.